Companies: 10,795·Total market cap: $144.5T
Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLANASDAQHealthcare● Active
$106.56
$-2.11(-1.94%)
Market Cap$1.3B
P/E Ratio
52W High$151.18
52W Low$20.2
Overview

Palvella Therapeutics, Inc. (PVLA) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · PVLA · as of Mar 31, 2026

Latest filing snapshot

29
+15+107.14%vs prior year

Palvella Therapeutics, Inc. (PVLA) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
29
Change (1Y)
+15
Growth % (1Y)
+107.14%
Revenue / Employee
Net Income / Employee
$-1.44M
Market Cap
$1.3B

PVLA Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-3129+15+107.14%
2025-03-3114-32-69.57%
2024-03-2946-81-63.78%
2023-03-31127+3+2.42%
2022-03-02124+13+11.71%
2021-03-31111-3-2.63%
2020-03-13114+7+6.54%
2019-03-18107+39+57.35%
2018-03-1568+19+38.78%
2017-03-3049+11+28.95%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
ProKidney Corp.
PROK
ProKidney Corp.
204
#2
Kura Oncology, Inc.
KURA
Kura Oncology, Inc.
192
#3
EyePoint Pharmaceuticals, Inc.
EYPT
EyePoint Pharmaceuticals, Inc.
165
#4
Nanobiotix S.A.
NBTX
Nanobiotix S.A.
108
#5
GH Research PLC
GHRS
GH Research PLC
50
#6
Arbutus Biopharma Corporation
ABUS
Arbutus Biopharma Corporation
44
#7
Palvella Therapeutics, Inc.
PVLA
Palvella Therapeutics, Inc.YOU
29
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · PVLA peer comparison

About PVLA employees

PVLA Employees · Headcount

Palvella Therapeutics, Inc. (PVLA) employee data is sourced from the annual SEC 10-K filing. As of 2025, Palvella Therapeutics, Inc. had 29 full-time employees globally. Full-time employees only. Global consolidated headcount.

Palvella Therapeutics, Inc.'s workforce increased by 15 (107.14%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

PVLA Employees · 5 questions

As of the latest SEC 10-K filing (2025), Palvella Therapeutics, Inc. had 29 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Palvella Therapeutics, Inc. employee counthow many employees does Palvella Therapeutics, Inc. havePVLA total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-31